Brevan Howard Capital Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$740K Sell
25,940
-21,152
-45% -$455K 0.01% 1230
2026
Q1
$540K Sell
47,092
-43,431
-48% -$612K ﹤0.01% 1257
2025
Q4
$1.3M Sell
90,523
-6,079
-6% -$105K 0.01% 653
2025
Q3
$1.83M Sell
96,602
-368,616
-79% -$6.07M 0.01% 607
2025
Q2
$9.97M Buy
465,218
+419,927
+927% +$6.24M 0.06% 185
2025
Q1
$594K Buy
+45,291
New +$672K 0.01% 682
2024
Q4
Sell
-22,525
Closed -$478K 1330
2024
Q3
$478K Buy
+22,525
New +$406K ﹤0.01% 691
2024
Q1
Sell
-19,845
Closed -$182K 1265
2023
Q4
$182K Buy
+19,845
New +$137K ﹤0.01% 896

Other funds holding OSCR

Brevan Howard Capital Management's OSCR Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Oscar Health (OSCR) stake by 45% in Q2 2026, selling an estimated $455K and leaving 25,940 shares worth $740K. The position accounts for 0.01% of the portfolio, ranked #1230.

Brevan Howard Capital Management first reported a position in OSCR in Q4 2023 and has held it in 8 quarters since. The position peaked at $9.97M in Q2 2025. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Brevan Howard Capital Management held 25,940 shares of Oscar Health worth $740K as of Q2 2026.
  • Brevan Howard Capital Management sold 21,152 Oscar Health shares in Q2 2026, an estimated $455K.
  • Oscar Health made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1230 holding.
  • Brevan Howard Capital Management first reported a position in Oscar Health in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Oscar Health position peaked at $9.97M in Q2 2025.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.